Colon cancer – recently approved drug for breast cancer, Enhertu, show promise
Colon cancer treated with Enhertu Enhertu is an antibody-drug conjugate composed of a chemotherapy bound to an anti-HER2 antibody. Recently, in December 2019, Enhertu received accelerated approval by the FDA…